Loading...
OX40 agonist immunotherapy expands tumor reactive CD8 T cells with a unique T cell receptor repertoire and synergizes with PDL-1 blockade to promote tumor regression
Saved in:
| Published in: | J Immunother Cancer |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4288330/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2051-1426-2-S3-O18 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|